(0.36%) 5 118.25 points
(0.42%) 38 402 points
(0.50%) 16 007 points
(-1.69%) $82.43
(4.84%) $2.02
(0.20%) $2 352.00
(0.21%) $27.59
(4.18%) $960.65
(-0.22%) $0.933
(-0.35%) $10.99
(-0.53%) $0.796
(1.69%) $93.43
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 12.91%
0.67% $ 12.00
Live Chart Being Loaded With Signals
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology...
Stats | |
---|---|
Volumen de hoy | 112 870 |
Volumen promedio | 371 546 |
Capitalización de mercado | 4.38B |
EPS | $0 ( 2024-02-21 ) |
Próxima fecha de ganancias | ( $0.940 ) 2024-05-01 |
Last Dividend | $0.0970 ( 2010-08-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.41 |
ATR14 | $0.00800 (0.07%) |
Volumen Correlación
BAUSCH HEALTH COMPANIES Correlación
10 Correlaciones Más Positivas | |
---|---|
HOM-UN.TO | 0.907 |
CJR-B.TO | 0.898 |
MTY.TO | 0.893 |
GOOS.TO | 0.885 |
ERO.TO | 0.882 |
LUN.TO | 0.88 |
LB.TO | 0.877 |
CARS.TO | 0.875 |
IGM.TO | 0.872 |
D-UN.TO | 0.871 |
10 Correlaciones Más Negativas | |
---|---|
QBTL.TO | -0.877 |
UNS.TO | -0.87 |
SBB.TO | -0.855 |
E.TO | -0.844 |
ABCT.TO | -0.836 |
SFC.TO | -0.822 |
THNC.TO | -0.822 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BAUSCH HEALTH COMPANIES Correlación - Moneda/Commodity
BAUSCH HEALTH COMPANIES Finanzas
Annual | 2023 |
Ingresos: | $8.76B |
Beneficio Bruto: | $6.20B (70.78 %) |
EPS: | $-1.620 |
FY | 2023 |
Ingresos: | $8.76B |
Beneficio Bruto: | $6.20B (70.78 %) |
EPS: | $-1.620 |
FY | 2022 |
Ingresos: | $8.12B |
Beneficio Bruto: | $5.76B (70.90 %) |
EPS: | $-0.590 |
FY | 2021 |
Ingresos: | $8.43B |
Beneficio Bruto: | $6.04B (71.61 %) |
EPS: | $-2.64 |
Financial Reports:
No articles found.
BAUSCH HEALTH COMPANIES Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.598 | 2005-11-28 |
Last Dividend | $0.0970 | 2010-08-30 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $5.49 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.9 | -- |
Div. Sustainability Score | 4.74 | |
Div.Growth Potential Score | 3.23 | |
Div. Directional Score | 3.98 | -- |
Year | Amount | Yield |
---|---|---|
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
XFF.TO | Dividend Junior | 2023-09-25 | Quarterly | 10 | 2.28% | |
PPL.TO | Dividend King | 2023-09-14 | Bi-Monthly | 22 | 3.95% | |
FCSB.TO | Dividend Junior | 2023-08-28 | Monthly | 6 | 1.28% | |
ZVU.TO | Dividend Junior | 2023-06-28 | Quarterly | 7 | 1.27% | |
TQCD.TO | Dividend Knight | 2023-08-29 | Monthly | 6 | 2.50% | |
MCB.TO | Dividend Knight | 2023-09-28 | Annually | 21 | 0.54% | |
CSAV.TO | Dividend Knight | 2023-08-25 | Monthly | 6 | 1.44% | |
XQB.TO | Dividend Knight | 2023-09-25 | Monthly | 15 | 1.55% | |
RBNK.TO | Dividend Knight | 2023-08-23 | Monthly | 8 | 2.47% | |
FTS.TO | Dividend Knight | 2023-11-16 | Quarterly | 30 | 2.58% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0685 | 1.500 | -1.370 | -2.06 | [0 - 0.5] |
returnOnAssetsTTM | -0.0219 | 1.200 | -0.731 | -0.878 | [0 - 0.3] |
returnOnEquityTTM | 0.618 | 1.500 | 4.24 | 6.36 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.301 | 0.800 | 8.50 | 6.80 | [1 - 3] |
quickRatioTTM | 0.685 | 0.800 | -0.679 | -0.543 | [0.8 - 2.5] |
cashRatioTTM | 0.220 | 1.500 | 9.89 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.819 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0.725 | 1.000 | -0.843 | -0.843 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.09 | 2.00 | 8.97 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.30 | 2.00 | 8.85 | 10.00 | [0 - 20] |
debtEquityRatioTTM | -21.91 | -1.500 | -10.00 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.708 | 1.000 | 1.537 | 1.537 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.110 | 1.000 | 9.80 | 9.80 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0489 | 1.000 | -0.839 | -0.839 | [0.2 - 2] |
assetTurnoverTTM | 0.320 | 0.800 | -1.199 | -0.959 | [0.5 - 2] |
Total Score | 4.74 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.16 | 1.000 | -0.623 | 0 | [1 - 100] |
returnOnEquityTTM | 0.618 | 2.50 | 6.30 | 6.36 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.30 | 2.00 | 9.23 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.09 | 2.00 | 8.97 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.143 | 1.500 | -4.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.125 | 1.000 | 9.37 | 0 | [0.1 - 0.5] |
Total Score | 3.23 |
BAUSCH HEALTH COMPANIES
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico